Literature DB >> 28850312

Favorable and Durable Response to Pazopanib in Metastatic Refractory Paraganglioma.

Sandipkumar Patel1, Dwight Owen1, Carl R Schmidt1, Lawrence S Kirschner1, John Phay1, Lawrence Shirley1, Mary Dillhoff1, Pamela Brock1, Allan Espinosa1, Manisha H Shah1, Bhavana Konda1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28850312     DOI： 10.1200/JOP.2017.024984

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  2 in total

1.  Durable Response to Pazopanib in Recurrent Metastatic Carotid Body Paraganglioma.

Authors:  Bader Alshamsan; Jean Paul Atallah
Journal:  Case Rep Oncol       Date:  2020-09-30

2.  Sunitinib Treatment for Advanced Paraganglioma: Case Report of a Novel SDHD Gene Mutation Variant and Systematic Review of the Literature.

Authors:  Franz Sesti; Tiziana Feola; Giulia Puliani; Roberta Centello; Valentina Di Vito; Oreste Bagni; Andrea Lenzi; Andrea M Isidori; Vito Cantisani; Antongiulio Faggiano; Elisa Giannetta
Journal:  Front Oncol       Date:  2021-06-17       Impact factor: 6.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.